Next Article in Journal
Structural Investigation of Hesperetin-7-O-Glucoside Inclusion Complex with β-Cyclodextrin: A Spectroscopic Assessment
Next Article in Special Issue
Chinese Cordyceps: Bioactive Components, Antitumor Effects and Underlying Mechanism—A Review
Previous Article in Journal
Natural Products in Mitigation of Bisphenol A Toxicity: Future Therapeutic Use
Previous Article in Special Issue
Anti-Inflammatory and Anti-Rheumatic Potential of Selective Plant Compounds by Targeting TLR-4/AP-1 Signaling: A Comprehensive Molecular Docking and Simulation Approaches
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Phytochemical Compounds and Pharmacological Properties of Larrea tridentata

by
Ana Lizet Morales-Ubaldo
1,
Nallely Rivero-Perez
1,
Benjamín Valladares-Carranza
2,
Alfredo Madariaga-Navarrete
3,
Rosa Isabel Higuera-Piedrahita
4,
Lucía Delgadillo-Ruiz
5,
Rómulo Bañuelos-Valenzuela
5 and
Adrian Zaragoza-Bastida
1,*
1
Área Académica de Medicina Veterinaria y Zootecnia, Instituto de Ciencias Agropecuarias, Universidad Autónoma del Estado de Hidalgo, Rancho Universitario Av. Universidad km 1, EX-Hda de Aquetzalpa, Tulancingo 43600, Hidalgo, Mexico
2
Facultad de Medicina Veterinaria y Zootecnia, Universidad Autónoma del Estado de México, El Cerrillo Piedras Blancas, Toluca 50090, Estado de Mexico, Mexico
3
Área Académica de Ciencias Agrícolas y Forestales, Universidad Autónoma del Estado de Hidalgo, Instituto de Ciencias Agropecuarias, Rancho Universitario Av. Universidad km 1, EX-Hda de Aquetzalpa, Tulancingo 43600, Hidalgo, Mexico
4
Facultad de Estudios Superiores Cuautitlán, Universidad Nacional Autónoma de México, Carretera Cuautitlán-Teoloyucan km 2.5, San Sebastián Xhala, Cuautitlán 54714, Estado de Mexico, Mexico
5
Unidad Académica de Medicina Veterinaria y Zootecnia, Universidad Autónoma de Zacatecas, Kilómetro 31.5 Carretera Panamerica, Fresnillo 98500, Zacatecas, Mexico
*
Author to whom correspondence should be addressed.
Molecules 2022, 27(17), 5393; https://doi.org/10.3390/molecules27175393
Submission received: 9 July 2022 / Revised: 19 August 2022 / Accepted: 21 August 2022 / Published: 24 August 2022
(This article belongs to the Special Issue Bioactive Compounds in Food Bioscience and Pharmacology)

Abstract

:
For centuries, traditional medicine from plants (phytotherapy) was the only treatment for infectious and non-infectious diseases. Although it is still practiced in several countries with excellent therapeutic results, it is frequently underestimated because, unlike Western medicine, it is not based on an empirical scientific foundation. However, interest in the search for plant-based therapeutic resources has been stimulated by disciplines such as phytochemistry and the side effects of conventional pharmacological therapies. For example, Larrea tridentata is a perennial shrub used in traditional medicine in northern Mexico and the southern United States to treat infertility, rheumatism, arthritis, colds, diarrhea, skin problems, pain, inflammation and excess body weight. Scientific research has revealed its beneficial effects—antioxidant, antitumor, neuroprotective, regenerative, antibacterial, antiviral, antifungal, anthelmintic, antiprotozoal and insecticidal—although reports indicate that some compounds in Larrea tridentata may be hepatotoxic and nephrotoxic. Therefore, the aim of this review was to highlight the updates regarding phytochemical compounds and the pharmacological properties of Larrea tridentata.

Graphical Abstract

1. Introduction

Larrea tridentata is a perennial shrub of Mexico and the United States that is used to treat a variety of illnesses. This species belongs to the Zygophyllaceae family, comprising about 30 genera and 250 species and found mainly in warmer and drier regions (Table 1) [1,2,3].
L. tridentata is commonly known as chaparral and greasewood in the United States and guamis, fake caper, hediondilla and gobernadora in Mexico. It grows from 0.5 to 3.5 m and has little aroma. The stem has numerous branches with lanceolate green-yellowish leaves. Its flowers are yellow, and the fruit is ovoid with fine white hairs and contains a black seed [2,4].
This plant is well known in both Mexico and the USA for its effectiveness in treating a variety of illness: infertility, rheumatism, arthritis, diabetes, gall and kidney stones, colds, diarrhea, skin problems, overweight, pain and inflammation. It also has uses in industry and as forage. Some studies have centered on its bioactive compounds, mainly to evaluate its anti-inflammatory, antiviral, antifungal, antibacterial, antioxidant and neuroprotective properties [2,4,5,6,7,8]. The aim of this review was to highlight the updates regarding phytochemical compounds and the pharmacological properties of Larrea tridentata.

2. Methodology

To carry out the present review, a comprehensive search was performed in the following databases: PubMed, ScienceDirect and Google scholar for studies published from 2010 to 2022, since a previous literature review was published in 2009. The following headings and keywords were used: Larrea tridentata, gobernadora, creosote bush, bioactive compounds and biological activities. Duplicate papers were removed, the data were screened, irrelevant work was excluded and full-text documents were then screened. Inclusion criteria included several factors, involving original articles or reviews and work on natural or chemical compounds. Exclusion criteria were inadequate methods and lack of access to the full text.

3. Phytoconstituents

L. tridentata is a species rich in bioactive compounds—tannins, flavonoids, saponins, phytoestrogens and terpenes—and bioactive molecules: ellagic acid, gallic acid, catechins, methyl gallate, cinnamic acid resorcinol, kaempferol, quercetin, nordihydroguaiaretic acid (NDGA), thymol and carvacrol [9,10,11,12,13]. Table 2 shows the main active constituents isolated from L. tridentata [14,15,16,17,18,19,20,21,22,23,24].

Isolation of New Compounds

In recent years, many studies have centered on elucidating new compounds. Jitsuno and Mimaki (2010) [25] performed a study that isolated 13 new compounds, identified as triterpene glycosides from the aerial parts of L. tridentata. For their part, Yokosuka et al. (2011) [26] isolated two new lignan glycosides called larrealignans. In a study carried out by Favela-Hernández et al. (2012) [27], a furanoid lignan from the leaves of Larrea tridentata, 4-epi-larreatricin, was isolated. Schmidt et al. (2012) [28], isolated nine lignans (dibenzylbutanes, epoxylignans and aryltetralins), six flavonoids and one ester.
Recently, two new cyclolignans were elucidated as 4,4′-dihydroxy-3-methoxy-6,7′-cyclolignan and 3,4-dihydroxy-3′,4′-dimethoxy-6,7′-cyclolignan [29]. Table 3 summarizes some of the new isolated compounds.

4. Pharmacological Activities

4.1. Antioxidant Activity

Antioxidant compounds are widely distributed in the plant kingdom, and in this regard, Martins et al. in 2010 evaluated the antioxidant capacity of L. tridentata through ferric reducing/antioxidant power (FRAP) and free radical-scavenging capacity techniques. They used 2,2-diphenyl-2-picrylhydrazyl (DPPH) radical-scavenging assays, and the data showed high antioxidant activity, which was attributed to elevated concentration of phenolic compounds and NDGA [30].
In a study performed by Rahman et al. (2011), the modulatory effects of L. tridentata and its associated compound NDGA were studied on acute inflammatory and oxidative stress responses in mouse skin induced by 12-O-tetradecanoylphorbol-13-acetate (TPA). They determined that pre-treatment with NDGA before the TPA application mitigated cutaneous lipid peroxidation and inhibited production of hydrogen peroxide. In addition, glutathione levels and antioxidant enzymes were restored, and the activity of myeloperoxidase and xanthine oxidase as well as skin edema formation were lowered [31].
In 2018, Aguirre-Joya et al. reported antioxidant capacity after evaluating ABTS.+ radical cation-scavenging activity assay, DPPH, lipid oxidation inhibition (LOI) and FRAP. The antioxidants identified were NDGA, quercetin and kaempferol [32].
Skouta et al. (2018) determined the antioxidant activity of three different extracts of L. tridentata (ethanol, ethanol–water and water), through DPPH, ABTS, superoxide, FRAP activity and nitric oxide (NO) assays, determining that ethanol–water (60:40) extract had the most efficient antioxidant properties, with values of 111.7 ± 3.8 µg/mL (DPPH), 8.49 ± 2.28 µg/mL (ABTS), 0.43 ± 0.17 µg/mL (superoxide) and 230.4 ± 130.4 µg/mL (NO). In addition, nine compounds were identified with antioxidant properties, among which were justicidin B and beta peltain [33].
Morán-Santibañez et al. (2019) reported that an ethanol–water extract from L. tridentata leaves mitigates cytotoxicity caused by oxidative stress in human cells. In addition, because of its cytoprotective activity against oxidative stress, the extract reduced the levels of different apoptosis hallmarks, thereby showing it to be a natural anti-apoptotic [34].

4.2. Antitumor Activity

The main compound of Larrea tridentata (NDGA) showed antitumor effects in bladder T24 cancer cells in vitro. The reactive oxygen species (ROS) levels were evaluated, and after 72 h of incubation, NDGA had reduced T24 cell viability in a dose-dependent manner. Apoptosis also increased at 48 h, and a dose of 20 μM of NDGA promoted mitochondrial stress by inducing oxygen consumption alterations just as in cancer cell death. This suggested that the antitumor effects of NDGA in T24 cells were related to its ability to induce mitochondrial alteration [35].
Probst et al. (2017) reported that lipoxygenase (LOX) inhibitors, such as NDGA, protect acute lymphoblastic leukemia (ALL) cells from RSL3-stimulated lipid peroxidation, reactive oxygen species generation (ROS) and cell death [36].

4.3. Neuroprotective Effects

NDGA has shown protective effects in the acute phase of stroke. In a 2014 transient ischemia rat model study carried out by Zhang et al., NDGA promoted neurogenesis and angiogenesis after 28 days of ischemia and reperfusion by suppressing semaphorin 3A expression [37].
Some studies have also centered on the use of natural products to treat neurodegenerative disorders, such as Alzheimer´s disease (AD) [38]. In this regard, Siddique and Ali (2017) evaluated the effect of NDGA on transgenic Drosophila expressing wild-type human Aβ-42 in the brain. Data showed that exposure to doses of 20, 40, 60 and 80 μM of NDGA reduced symptoms, increased life span, delayed the loss of climbing activity and showed a dose-dependent decrease in the activity of caspase 3 and 9 and acetylcholinesterase, which suggested an anti-apoptotic and neuroprotective role. Furthermore, NDGA improved memory loss in flies with AD, demonstrating that this compound reduced neurotoxic, motor and cognitive impairments [39].

4.4. Regenerative Applications

Larrea tridentata and its pure compounds have been widely used in different fields, including tissue engineering. Tovar-Carrillo et al. (2020) analyzed the compatibility of the in vitro and in vivo properties of cellulose hydrogels enriched with L. tridentata that had been implanted intramuscularly in female rats. At the end of the in vivo assay (90 days), no evidence of inflammation, toxicity or death was observed; furthermore, it was observed that the addition of L. tridentata improved cytocompatibility, demonstrating that enriched hydrogels can be used as regenerative scaffolds [40].

4.5. Hepatoprotective Effect

Del Vecchyo-Tenorio et al. (2016) stated that ethanolic extract of L. tridentata is useful in metabolic syndrome (MS) treatment since it was reported that the addition of the extract in a high fat and cholesterol diet (HFD) in hamsters with signs of MS reduced plasma triglycerides, total cholesterol, insulin and leptin and improved insulin sensitivity. On the other hand, in a standard diet enriched with the same extract, the effects were higher since reduced body and liver weight, glucose concentration, cholesterol, insulin and leptin in serum were increased in addition to insulin sensitivity. According to the authors, these effects were associated with lower lipid peroxidation and increased antioxidant capacity in the liver [41].
Chan et al. (2018), in a murine model with liver injury produced by the American Lifestyle-Induced Obesity Syndrome diet (ALIOS), demonstrated that the coadminstration of NDGA reduced body and epididymal fat weight and levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST) and triglycerides in the liver. It also improved insulin sensitivity because this compound induced the activation of PPARα, a regulator of fatty acid oxidation, and the mRNA of Cpt1c and Cpt2, genes involved in fatty acid oxidation; furthermore, the NDGA reduced liver stress and the expression of (CASP3), an apoptosis signaling protein, and improved the hepatic expression of antioxidant enzymes and the proteins GPX4 and PRDX3 [42].
In a similar study, Han et al. (2019) evaluated the effect of NDGA (2.5 g/kg of diet) on mice fed a diet high in trans-fat, cholesterol and fructose (HTF) for 16 weeks. The NDGA reduced body and liver weight and the liver-to-body weight ratio in HTF-fed mice also decreased non-esterified fatty acids and serum insulin. The results suggested that NDGA could mitigate liver damage and the accumulation of triglycerides. A glucose tolerance test revealed that mice treated with NDGA showed lower levels of glucose, steatosis and fibrosis. Furthermore, this compound increased fatty acid oxidation and reduced both ER and oxidative stress [43].

4.6. Renal Effects

Some studies have evaluated the renal effects of the major compound of L. tridentata. Zuntilde et al. (2012) reported that NDGA prevented renal dysfunction, histological damage and oxidative stress, as well as decreasing the activity of the renal antioxidant enzymes glutathione peroxidase, glutathione reductase, glutathione-S-transferase and catalase. It also affected mitochondrial activity, which is why NDGA was considered to be nephroprotective [44].
Zúñiga-Toalá et al. (2013) [45] reported that pretreatment with NDGA had a protective effect on ischemia–reperfusion renal (I/R) damage. It attenuated tubular epithelium damage since this compound induced, in vivo and in vitro, nuclear factor erythroid 2-related factor 2 (Nrf2) nuclear translocation in rats that had a uni-nephrectomy and I-R damage and apoptosis. The authors of this study suggest that the indirect antioxidant effect of NDGA may have been involved in the cytoprotective effect of the I-R injury, and previous studies support this result. Rojo et al. (2012) reported that NDGA increased the level of the Nrf2 protein and expression of heme oxygenase-1 (HO-1) in kidney cells through the activation of multiple signaling cascades [46].

4.7. Anti-Inflammatory Activity

In an in vivo study carried out by Rahman et al. (2011), mice treated with NDGA (15 and 25 μmol) before a double application of 12-O-tetradecanoylphorbol-13-acetate (TPA), showed significantly reduced activity of myeloperoxidase, one of the main enzymes related with polymorphonuclear (PMN) activation. It was also observed that animals treated with this compound showed a lower edema response compared with those treated only with TPA. Histological findings showed that the TPA application caused an increase in the epidermal layer, the infiltration of polymorphonuclears (PMNs) and intercellular edema in the skin. It also caused inflammatory responses in the tissue in contrast to those animals that had been pretreated and treated with NDGA, which mitigated inflammation and any histological change [31].
Xue et al. (2013) evaluated the in vivo anti-inflammatory effects of NDGA in spinal cord injury (SCI). Myeloperoxidase (MPO) levels were measured after 3 days of the SCI process, and the results showed that NDGA reduced neutrophil infiltration after injury and infiltration of macrophages–microglia. In this study, NDGA decreased inflammatory factors (IL-1β and TNF-α) associated with spinal cord damage [47].

4.8. Growth Performance

García-López et al. (2018) evaluated the effects of the dietary addition of whole plant, leaves and powdered aqueous extract of L. tridentata on the growth, organ weight and serum hepatic enzymes of Cobb broiler chickens. The treatments were added to a basal diet and randomly assigned to 200 Cobb broilers one day old. The authors concluded that those fed the L. tridentata aqueous extract had a better performance response; furthermore, the decrease in enzyme hepatic levels means that the extract could be considered a natural growth promoter [48].
In a similar study, dried aerial parts of L. tridentata were added to a sheep diet at a rate of 0, 5 and 10% over 60 days. An analysis indicated that the aerial parts contained 85% dry matter, 12% crude protein, 58% neutral detergent fiber and 10% ash, which was similar to hay or conventional silage. The pH values were similar to that of the control group. Despite the data in feed efficiency, there was no significant statistical difference between diets with and without the L. tridentata biomass. The study concluded that inclusion of L. tridentata in the diet may be suitable for finishing [49].

4.9. Hypoglycemic Effects

Roškar et al. (2016), reported that NDGA demonstrated antidiabetic activity in vivo since this compound inhibited α-amylase, α-glucosidase and dipeptidyl peptidase 4, enzymes associated with postprandial glucose management [50]. The pharmacological activities of L. tridentata and its related bioactive compounds are summarized in Table 4.

4.10. Antibacterial Activity

Seven compounds from the chloroformic L. tridentata extract were isolated and identified: dihydroguaiaretic acid; 4-epi-larreatricin and 3′-demethoxy-6-O-demethylisoguaiacin (lignans) and 5,4′-dihydroxy-3,7,8,3-tetramethoxyflavone, 5,4′-dihydroxy-3,7,8-trimethoxyflavone, 5,4′-dihydroxy-7-methoxyflavone and 5,8,4′-trihydroxy-3,7-dimethoxyflavone (flavonoids). All of these were evaluated through the determination of minimal inhibitory concentration (MIC) against Gram-negative (Stenotrophomona maltophilia, Escherichia coli, Acinobacter baumannii, Haemophilus influenzae, Pseudomonas aeruginosa, Klebsiella pneumoniae and Enterobacter cloacae) and Gram-positive (Staphylococcus aureus, S. aureus (MR), Streptococcus pneumoniae, Listeria monocytogenes and Enterococcus faecalis) bacteria. The results showed that six of the compounds had antibacterial activity in a range of concentrations from 12.5 to >50 µg/mL, with the most active compound being 3′-demethoxy-6-O-demethylisoguaiacin. It showed antibacterial activity against all evaluated bacteria; therefore, it was evaluated against clinical isolates of E. faecalis, S. aureus and S. aureus (MR) and attained MIC values from 12.5 to 50 µg/mL. The mechanism of action of this compound affected the proteins of the ATP-binding cassette (ABC) transport system, thereby causing bacteria death [27,51].
In a study performed by Mendez et al. (2012) [52], different L. tridentata leaf extracts (water, ethanol, cocoa butter and lanolin) were evaluated against E. aerogenes, E. coli, S. typhi and S. aureus. The results showed that ethanolic extract had the highest growth inhibitory effects on E. coli and S. aureus. Snowden et al. (2014) evaluated L. tridentata leaf and flower extracts against S. aureus and obtained an MIC of 60 µg/mL, demonstrating that the extracts had bacteriostatic and bactericidal activity [53].
For their part, Martins et al. (2013) [54] evaluated the antibacterial activity of L. tridentata crude methanolic (CME) extract, hexane (H), dichloromethane (DCM), ethyl acetate (EA) and ethanol (Et) fractions and the compound NDGA. Antibacterial activity was determined through agar diffusion, and the results showed that CME, DCM, EA and NDGA were active against Gram-positive bacteria (S. aureus, S. aureus methicillin-resistant (MRSA), Staphylococcus saprophyticus, Staphylococcus epidermidis and Enterococcus faecalis). An MIC from 31.3 to 125 µg/mL was obtained for the EA fraction, the most active, and 31.3 µg/mL for MRSA, the most sensitive bacterium, which was at a concentration lower than the reference antibiotic, tetracycline (64 µg/mL). In addition, the authors identified three bioactive compounds: quercetin, kaempferol and NDGA, all of which had reported antibacterial activity [54].
The combination of NDGA and conventional antibiotics (gentamicin, neomycin and tobramycin) showed synergistic activity (97–100%) against 200 clinical isolations of methicillin-sensitive S. aureus (MSSA) and methicillin-resistant S. aureus (MRSA). In addition, when the MIC values of these combinations were determined, all antibiotics were reduced 2 to 128-fold against MSSA and 2 to 256-fold against MRSA. Moreover in the time-kill assay, NDGA improved the effect of three antibiotics in in vitro and in vivo murine models. According to the authors, the enhancement of antibiotic efficacy was due to the ability of NDGA to permeabilize bacterial membranes [55].
The antibacterial effects of thymol and carvacrol in the L. tridentata ethanolic extract were demonstrated in a study carried out by Delgadillo-Ruiz et al. (2017) [12]. Meso-dihydroguaiaretic acid derivatives (esters, ethers and amino-ethers) were tested against Gram-positive and Gram-negative drug-resistant bacterial strains, showing that Gram-positive bacteria (MR S. aureus, VR E. faecium, LR S. epidermis and LR S. haemolyticus) were more sensitive, and even two amino-ethers were more active than levofloxacin [56].
A direct comparison of the antibacterial activity against nonantibiotic-resistant S. aureus and two different strains of antibiotic-resistant S. aureus was performed by Gerstel et al. (2018) [57]. They determined an MIC range of 0.35–15 µg/mL for L. tridentata extract. In 2019, Itza-Ortiz stated that L. tridentata extract at 30% generated bacterial growth inhibition halos (BGIHs) against a wide range of Gram-negative and Gram-positive bacteria (0.67–1.73 mm). The extract was the most active against S. aureus and S. enterica when the BGIHs were 1.73 and 1.57 mm, respectively [58].
From the chloroform extract of L. tridentata, the compounds 4,4′-dihydroxy-3-methoxy-6,7′-cyclolignan, 3,4-dihydroxy-3′,4′-dimethoxy-6,7′-cyclolignan, meso-dihydroguaiaretic acid, 3′-demethoxyisoguaiacin, 3′-demethoxy-6-O-demethylisoguaiacin, nordihydroguaiaretic acid, 5,4′-dihydroxy-3,7,8-trimethoxyflavone and 5,8,4′-trihydroxy-3,7-dimethoxyflavone were isolated. These were active against nine multidrug-resistant clinical isolates at concentrations from 6.25 to >50 µg/mL [29]. In a further study, seven amino-ether derivatives from lignan 4,4′-dihydroxy-3-methoxy-6,7′-cyclolignan exhibited antibacterial activity against Gram-positive bacteria [59].
Turner et al. (2021) determined that the ethanolic extract of L. tridentata showed bactericidal activity against S. aureus (20 μg/mL), S. pyogenes (30 μg/mL), B. cereus (120 μg/mL), E. coli and P. aeruginosa (>1000 μg/mL); moreover, the authors determined that L. tridentata extract enhanced the activity of some β-lactam antibiotics, suggesting the presence of a β-lactam-type antibiotic in the extract [60].
Recently, Morales-Ubaldo et al. (2022) evaluated the antibacterial activity of a hydroalcoholic extract, fractions (aqueous and ethyl acetate) and subfractions from organic fractions, all of which were derived from L. tridentata aerial parts. When measured against the reference and multidrug-resistant bacterial strains associated with bovine mastitis, the data showed that the antibacterial activity of L. tridentata was associated with the pure compound nor 3’-demethoxyisoguaiacin, which exhibited the highest bactericidal effects [61].

4.11. Antimycobacterial Activity

In 2018, according to the World Health Organization (WHO), 1.5 million people died from tuberculosis (TB), one of the top 10 causes of death; moreover, multidrug-resistant TB (MDR-TB) represents a public health threat [62].
In this respect, studies have centered on the search for agents capable of acting against this bacteria. Favela-Hernández et al. (2012) tested seven compounds against both sensitive and MDR Mycobacterium tuberculosis strains and obtained an MIC of 12.5 to >50 µg/mL. The compounds responsible for this activity were dihydroguaiaretic acid 4-epi-larreatricin, 3′-demethoxy-6-O-demethylisoguaiacin, 5,4′-dihydroxy-3,7,8,3-tetramethoxyflavone and 5,4′-dihydroxy-3,7,8-trimethoxyflavone, [27].
In 2014, Clemente-Soto et al. found that a concentration of 50 µg/mL of meso-dihydroguaiaretic acid (MDGA) inhibited bacterial growth after 48 h [63]; in a similar study, Reyes-Melo et al. (2017) [56] found that MDGA derivatives affected sensitive and multidrug-resistant M. tuberculosis strains; MIC values ranged from 3.125 to 50 µg/mL. Furthermore, the authors determined that this compound had no cytotoxic effects. Guzmán-Beltrán et al. (2016) determined that a concentration of 250 µg/mL of NDGA exerted bactericidal activity [64].
The study carried out by Nuñez-Mojica et al. (2021) determined that eight compounds isolated from L. tridentata leaves exhibited activity against a susceptible and drug-resistant M. tuberculosis strain, and in a further study, amino-ether derivatives from lignan 4,4′-dihydroxy-3-methoxy-6,7′-cyclolignan exhibited antitubercular activity. The most active the compound against the multidrug-resistant M. tuberculosis strain was identified as 4C (6.25 µg/mL) [29,59].

4.12. Antiviral Activity

The in vitro antiviral activity of the methylated derivative of NDGA, terameprocol (TMP), was tested to determine if it could inhibit poxvirus (CPXV) growth. The authors performed CPXV plaque-reduction assays containing varied concentrations of TMP: 3.125, 6.25 and 12.5 µM. The results showed a dose-dependent decrease in CPXV plaque size and a reduction in the total number of plaques that could be detected. It was reported that the compound inhibited poxvirus growth in vitro by preventing the efficient spread of virus particles from cell to cell [65].

4.13. Antiprotozoal Activity

In the study carried out by Schmidt et al. (2012), dichloromethane extract from aerial parts of L. tridentata was used for antiprotozoal screening against Trypanosoma brucei rhodesiense, Trypanosoma cruzi, Leishmania donovani and Plasmodium falciparum, which had IC50 values of 2.8, 14.6, 5.2 and 2.9 µg/mL, respectively. Nine lignans, six flavonoids and one ester of ferulic acid were isolated and evaluated. Lignan meso-nordihydroguaiaretic acid showed the majority of activity obtaining IC50 of 4.5, 33.1, 12.0 and 7.7 µM against the above-mentioned parasites, respectively [28].
In their study, Camacho-Corona et al. (2015), evaluated the organic extracts of six plants, including L. tridentata against Entamoeba histolytica, Giardia lamblia and Trichomonas vaginalis and obtained IC50 values of 100, 116 and 118 µg/mL, respectively [66].
It was also reported that Entamoeba histolytica, Giardia lamblia, and Naegleria fowleri are susceptible to six lignan compounds from L. tridentata. Compound 1 (NDGA) showed the highest activity against G. lamblia and N. fowleri (EC50 36 and 37 μM, respectively), and moderate activity against E. histolytica (EC50 =103 μM); compound 2 (3′-O-methyl-NDGA) showed similar results to compound 1 against N. fowleri (EC50 38 μM). In both cases these results were better than the standard drug (miltefosine EC50 = 54.5 μM). The other compounds showed activity from 49 to 235 μM. In addition, the authors suggested that the activity of compounds 1 and 2 against N. fowleri may be due to the modulation of cysteine protease activity in the trophozoites [67].

4.14. Anthelmintic Activity

Regarding parasitic infections in sheep, the anti-Haemonchus contortus properties of L. tridentata were reported by García et al. (2018). Sheathed and unsheathed worm larvae of H. contortus were incubated with hydro-methanolic extract at concentrations of 12.5, 25, 50, 100 and 200 mg/mL during 24, 48 and 72 h. At the highest concentration, the extract showed weak activity against sheathed larvae (30% mortality), but against unsheathed larvae activity increased to 70%; moreover, the authors found that the compounds identified in their study damaged the larval cuticle and that the worms coiled up and were lethargic [68].

4.15. Antifungal and Antibacterial Activity in Agricultural Crops

L. tridentata-lanolin, cocoa butter and water extracts were evaluated against Rhizoctonia solani, an agent of diseases associated with roots and tubers of different crops. The data showed that L. tridentata-lanolin extract at 500 ppm of total tannins inhibited 80% of mycelia, but when the tannins were increased to 2000 ppm, 100% inhibition was obtained. Cocoa butter extract required a concentration of 3000 ppm of total tannins to obtain the same inhibition percentage (100%), and water extract required 8000 ppm [69].
In the 2010 study carried out by Osorio et al., polyphenolic extract from L. tridentata leaves was evaluated against Pythium spp., Colletotrichum truncatum, Colletotrichum coccodes, Alternaria. alternata, Fusarium verticillioides, Fusarium solani, Fusarium sambucinum and Rhizoctonia solani, which are all associated with leaf and root diseases. Strong fungicidal activity was observed since the extract inhibited 100% of the fungal strains, except for F. verticillioides, for which inhibition was 75%; moreover, the extract was evaluated against 10 different single-spore isolates of Fusarium oxysporum. L. tridentata inhibited eight of them 100%, and one 75% [70].
Chávez-Solíz et al. (2014) reported that L. tridentata leaf extracts at concentrations of 1000 and 5000 mg/L of water, significantly reduced the severity of Podosphaera xanthii, one of the causative agents of powdery melon mildew [71]. Galván et al. (2014) reported that the best antifungal activity of L. tridentata aqueous extract (10 and 20%) was against Phytophthora capsici and Aspergillus flavus. After 48, 72 and 96 h, the two extract concentrations caused 100%inhibition in both fungal species [72].
L. tridentata leaf extract alone or in combination with potassium sorbate had positive effects against A. flavus in pH conditions 3, 4 and 5. Inhibited growth of 71.91, 69.33 and 70.06% (pH 3, 4 and 5, respectively) was achieved at a concentration of 1000 ppm. It increased to 81.48, 82.82 and 81.43% when the potassium sorbate was added in the same respective pH conditions. The authors determined that, together, both compounds demonstrated synergistic activity [73].
The in vitro antifungal activity of L. tridentata water, ethanol, lanolin and cocoa butter extracts against Phytophthora cinnamomi Rands was evaluated in a 2015 study by Castillo-Reyes et al. The data showed that ethanol extract caused 100% mycelium inhibition, and lanolin extract caused 80%. When MIC50 was determined, a concentration of 6.96 ppm was needed to inhibit 50% of mycelia growth; for lanolin extract, it was 183.6 ppm [74].
Peñuelas-Rubio et al. (2015) [75] reported that L. tridentata ethanolic and dichloromethane extracts inhibited fungal growth 75–100% against Alternaria tenuissima, Aspergillus niger, Penicillium polonicum and Rhizopus oryzae. In a similar study, ethanolic and dichloromethane extracts inhibited Fusarium oxysporum radicis-lycopersici 100%, while methanolic extract achieved 94% [76].
Aguirre-Joya et al. (2018) reported high fungistatic activity by using a bioactive film containing L. tridentata polyphenols, which achieved MIC50 values of 566, 558, 612 and 579 ppm for Alternaria alternata, Fusarium oxysporum, Botrytis cinereal and Colletotrichum gloeosporioides, respectively [32].
Recently, Morales-Ubaldo et al. (2021), reported the antibacterial activity of a hydroalcoholic extract and ethyl acetate fraction of L. tridentata, against multidrug-resistant phytopathogenic bacteria (Clavibacter michiganensis subsp. michiganensis, Pseudomonas syringae and Xanthomonas campestris). The authors found that the extract showed inhibitory activity at concentrations of 0.39–6.25 mg/mL and bactericidal effects at 0.78–12.5 mg/mL. The concentrations of ethyl acetate fraction were 0.39–3.12 and 0.78–6.25 mg/mL for MIC and MBC, respectively. According to the authors, their study is the first to report the antibacterial activity of L. tridentata against multidrug-resistant phytopathogenic bacteria [77].
For their part, Méndez-Andrade et al. (2021) used an aqueous extract from L. tridentata leaves as a source for reducing and stabilizing agents to obtain silver nanoparticles, which exert bactericidal activity against Clavibacter michiganensis. The authors reported that, at a concentration of 50 mg/L, disease incidence did not exceed 20%, and disease severity was reduced by 36% [78].

4.16. Insecticidal Activity

Pecan black aphids (Melanocallis caryaefoliae D.) were exposed to L. tridentata (stem and leaf) ethyl acetate, methanol, and water extracts at concentrations of 0.5, 1 and 2%. The authors determined that leaf extracts at 1% concentration showed 80 and 92% mortality in the aqueous and methanol extracts, respectively. Regarding stem extracts, the best effect was obtained when ethyl acetate and aqueous extracts (0.5%) were used. For all extracts, the greatest effect occurred 72 h after the treatment was applied. In addition, the repellent effect was evaluated and showed the best effects after 24 h: 65% repellence from 0.5% methanolic leaf extract; however, 1% ethyl acetate stem extract showed the best activity, repelling 50% of the pecan black aphids [79].
A similar study reported that 20% L. tridentata leaf extract reduced the incidence of horn flies (Haematobia irritans) on cows [80]. The larvicidal effect of L. tridentata extract (1 g/L) on mosquitoes was approximately 50% mortality (L3) [81]. Some of the pharmacological effects of L. tridentata related to infectious diseases are shown in Table 5.

5. Side Effects

There are reports stating that the products of L. tridentata may be associated with jaundice, cholestatic hepatitis and liver damage, which then progresses to cirrhosis and even fulminant liver failure. In addition, the main compound, NDGA, causes hepatotoxicity and nephrotoxicity in humans and death in mice (LD50 = 75 mg/kg). Contact dermatitis has also been attributed to L. tridentata [8,82,83,84,85,86].

6. Discussion and Future Prospects

L. tridentata has traditionally been used to treat a variety of diseases. In recent years several investigations have demonstrated the pharmacological properties of this botanical species, especially its antimicrobial activity. Before determining its effects in vitro on bacteria (human, animal, or plant), parasites, fungi and viruses, it is necessary to perform in vivo or in situ tests to support the efficacy of L. tridentata as an effective alternative method of treatment. In the same sense, further studies are needed to establish new strategies to improve its pharmacological properties and phytochemical content, such as the study by Nuñez-Mojica et al. (2022), in which the derivation of a known compound from L. tridentata led to 11 new antibacterial compounds [59]. In the same sense, is necessary to establish a dose-response relationship for extracts, fractions or pure compounds associated with their toxicological profile and their mechanism of action.

7. Conclusions

This review examined the pharmacological effects of L. tridentata, commonly known as gobernadora in Mexico and creosote bush in the USA. It was found that the aerial parts of L. tridentata are of great importance in both traditional medicine and pharmaceuticals for treatment of infectious and non-infectious diseases because of their antioxidant, neuroprotective, antitumoral, anti-inflammatory, regenerative, antifungal, insecticidal, anthelmintic, antiprotozoal and antibacterial activities. These are associated with such bioactive compounds as ellagic acid, gallic acid, catechins, methyl gallate, cinnamic acid resorcinol, kaempferol, quercetin, nordihydroguaiaretic acid (NDGA), thymol and carvacrol. However, nephrotoxic and hepatotoxic effects, mainly associated with NDGA, have been reported.

Author Contributions

Conceptualization and methodology, N.R.-P., A.L.M.-U. and A.Z.-B.; validation and formal analysis, N.R.-P., A.Z.-B., A.L.M.-U. and B.V.-C.; investigation and resources, N.R.-P., A.M.-N. and A.Z.-B.; data curation, A.Z.-B., A.L.M.-U. and L.D.-R.; writing—original draft preparation, A.L.M.-U., R.I.H.-P. and N.R.-P.; writing—review and editing R.B.-V., N.R.-P. and A.Z.-B.; supervision, N.R.-P. and A.Z.-B.; project administration, N.R.-P. and A.Z.-B.; funding acquisition, N.R.-P. and A.Z.-B. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Data are contained within the article.

Acknowledgments

The authors would like to acknowledge the Universidad Autónoma del Estado de Hidalgo (UAEH) for allowing us to conduct the study in its facilities. This study formed part of the PhD thesis of Ana Lizet Morales Ubaldo (Ciencias Agropecurias, Universidad Autónoma del Estado de Hidalgo).

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Woodson, R.E.; Schery, R.W.; Porter, D.M. Flora of Panama: Part VI. Family 88. Zygophyllaceae. Ann. Mo. Bot. Gard. 1969, 56, 1–7. [Google Scholar] [CrossRef]
  2. Arteaga, S.; Andrade-Cetto, A.; Cárdenas, R. Larrea tridentata (Creosote bush), an abundant plant of Mexican and US-American deserts and its metabolite nordihydroguaiaretic acid. J. Ethnopharmacol. 2005, 98, 231–239. [Google Scholar] [CrossRef] [PubMed]
  3. Integrated Taxonomy Information System (ITIS). Larrea tridentata (DC.) Coville. Available online: https://www.itis.gov/servlet/SingleRpt/SingleRpt?search_topic=TSN&search_value=29051#null (accessed on 21 August 2020).
  4. Rzedowski, J.; Calderón de Rzedowski, G. Zygophyllaceae. In Flora del Bajío y de Regions Adyacentes; Rzedowski, J., Calderón de Rzedowski, G., Eds.; Instituto de Ecología: Veracruz, México, 1994; Volume 30, pp. 11–15. [Google Scholar]
  5. Saldívar, R.H.L. Estado actual del conocimiento sobre las propiedades biocidas de la gobernadora [Larrea tridentata (DC) Coville]. Rev. Mex. Fitopatol. 2003, 21, 214–222. [Google Scholar]
  6. Gnabre, J.; Bates, R.; Huang, R.C. Creosote bush lignans for human disease treatment and prevention: Perspectives on combination therapy. J. Tradit. Complement. Med. 2015, 5, 119–126. [Google Scholar] [CrossRef] [PubMed]
  7. Manda, G.; Rojo, A.I.; Martínez-Klimova, E.; Pedraza-Chaverri, J.; Cuadrado, A. Nordihydroguaiaretic Acid: From Herbal Medicine to Clinical Development for Cancer and Chronic Diseases. Front. Pharmacol. 2020, 11, 151. [Google Scholar] [CrossRef] [PubMed]
  8. Aronson, J.K. Zygophyllaceae. In Meyler’s Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions; Elsevier: Amsterdam, The Netherlands, 2015; pp. 611–612. [Google Scholar]
  9. Ruiz, J.; Ascacio-Valdés, J.; Rodriguez, R.; Morales, D.; Aguilar, C. Phytochemical screening of extracts from some Mexican plants used in traditional medicine. J. Med. Plants 2011, 5, 2791–2797. [Google Scholar]
  10. Martins, S.; Aguilar, C.N.; Teixeira, J.A.; Mussatto, S.I. Bioactive compounds (phytoestrogens) recovery from Larrea tridentata leaves by solvents extraction. Sep. Purif. Technol. 2012, 88, 163–167. [Google Scholar] [CrossRef]
  11. Ascacio-Valdés, J.A.; Aguilera-Carbó, A.; Rodríguez-Herrera, R.; Aguilar-González, C. Análisis de ácido elágico en algunas plantas del semidesierto mexicano. Rev. Mex. Cienc. Farm. 2013, 44, 36–40. [Google Scholar]
  12. Delgadillo-Ruíz, L.; Bañuelos-Valenzuela, R.; Delgadillo-Ruíz, O.; Silva-Vega, M.; Gallegos-Flores, P. Composición química y efecto antibacteriano in vitro de extractos de Larrea tridentata, origanum vulgare, artemisa ludoviciana y ruta graveolens. Nova Sci. 2017, 9, 273–290. [Google Scholar] [CrossRef]
  13. Bañuelos-Valenzuela, R.; Delgadillo-Ruiz, L.; Echavarría-Cháirez, F.; Delgadillo-Ruiz, O.; Meza-López, C. Composición química y FTIR de extractos etanólicos de Larrea tridentata, Origanum vulgare, Artemisa ludoviciana y Ruta graveolens. Agrociencia 2018, 52, 309–321. [Google Scholar]
  14. National Center for Biotechnology Information. PubChem Compound Summary for CID 5281855, Ellagic Acid. Available online: https://pubchem.ncbi.nlm.nih.gov/compound/Ellagic-acid (accessed on 5 March 2021).
  15. National Center for Biotechnology Information. PubChem Compound Summary for CID 370, Gallic Acid. Available online: https://pubchem.ncbi.nlm.nih.gov/compound/Gallic-acid (accessed on 5 March 2021).
  16. National Center for Biotechnology Information. PubChem Compound Summary for CID 1203, Epicatechin. Available online: https://pubchem.ncbi.nlm.nih.gov/compound/Epicatechin (accessed on 5 March 2021).
  17. National Center for Biotechnology Information. PubChem Compound Summary for CID 7428, Methyl Gallate. Available online: https://pubchem.ncbi.nlm.nih.gov/compound/Methyl-gallate (accessed on 5 March 2021).
  18. National Center for Biotechnology Information. PubChem Compound Summary for CID 444539, Cinnamic Acid. Available online: https://pubchem.ncbi.nlm.nih.gov/compound/Cinnamic-acid (accessed on 5 March 2021).
  19. National Center for Biotechnology Information. PubChem Compound Summary for CID 5054, Resorcinol. Available online: https://pubchem.ncbi.nlm.nih.gov/compound/Resorcinol (accessed on 5 March 2021).
  20. National Center for Biotechnology Information. PubChem Compound Summary for CID 5280863, Kaempferol. Available online: https://pubchem.ncbi.nlm.nih.gov/compound/Kaempferol (accessed on 5 March 2021).
  21. National Center for Biotechnology Information. PubChem Compound Summary for CID 5280343, Quercetin. Available online: https://pubchem.ncbi.nlm.nih.gov/compound/Quercetin (accessed on 5 March 2021).
  22. National Center for Biotechnology Information. PubChem Compound Summary for CID 4534, Nordihydroguaiaretic Acid. Available online: https://pubchem.ncbi.nlm.nih.gov/compound/Nordihydroguaiaretic-acid (accessed on 5 March 2021).
  23. National Center for Biotechnology Information. PubChem Compound Summary for CID 6989, Thymol. Available online: https://pubchem.ncbi.nlm.nih.gov/compound/Thymol (accessed on 5 March 2021).
  24. National Center for Biotechnology Information. PubChem Compound Summary for CID 10364, Carvacrol. Available online: https://pubchem.ncbi.nlm.nih.gov/compound/Carvacrol (accessed on 5 March 2021).
  25. Jitsuno, M.; Mimaki, Y. Triterpene glycosides from the aerial parts of Larrea tridentata. Phytochemistry 2010, 71, 2157–2167. [Google Scholar] [CrossRef]
  26. Yokosuka, A.; Matsuo, Y.; Jitsuno, M.; Adachi, K.; Mimaki, Y. Larrealignans A and B, Novel Lignan Glycosides from the Aerial Parts of Larrea tridentata. Chem. Pharm. Bull. 2011, 59, 1467–1470. [Google Scholar] [CrossRef] [PubMed]
  27. Favela-Hernández, J.M.; García, A.; Garza-González, E.; Rivas-Galindo, V.M.; Camacho-Corona, M.R. Antibacterial and antimycobacterial lignans and flavonoids from Larrea tridentata. Phytother. Res. 2012, 26, 1957–1960. [Google Scholar] [CrossRef] [PubMed]
  28. Schmidt, T.J.; Rzeppa, S.; Kaiser, M.; Brun, R. Larrea tridentata—Absolute configuration of its epoxylignans and investigations on its antiprotozoal activity. Phytochem. Lett. 2012, 5, 632–638. [Google Scholar] [CrossRef]
  29. Núñez-Mojica, G.; Vázquez-Ramírez, A.L.; García, A.; Rivas-Galindo, V.M.; Garza-González, E.; Cuevas González-Bravo, G.E.; Toscano, R.A.; Moo-Puc, R.E.; Villanueva-Toledo, J.R.; Marchand, P.; et al. New cyclolignans of Larrea tridentata and their antibacterial and cytotoxic activities. Phytochem. Lett. 2021, 43, 212–218. [Google Scholar] [CrossRef]
  30. Martins, S.; Mussatto, S.; Aguilar, C.; Teixeira, J. Antioxidant capacity and NDGA content of Larrea tridentata (a desert bush) leaves extracted with different solvents. J. Biotechnol. 2010, 150, 500. [Google Scholar] [CrossRef]
  31. Rahman, S.; Ansari, R.A.; Rehman, H.; Parvez, S.; Raisuddin, S. Nordihydroguaiaretic Acid from Creosote Bush (Larrea tridentata) Mitigates 12-O-Tetradecanoylphorbol-13-Acetate-Induced Inflammatory and Oxidative Stress Responses of Tumor Promotion Cascade in Mouse Skin. Evid.-Based Complementary Altern. Med. 2011, 2011, 734–785. [Google Scholar] [CrossRef]
  32. Aguirre-Joya, J.A.; Pastrana-Castro, L.; Nieto-Oropeza, D.; Ventura-Sobrevilla, J.; Rojas-Molina, R.; Aguilar, C.N. The physicochemical, antifungal and antioxidant properties of a mixed polyphenol based bioactive film. Heliyon 2018, 4, e00942. [Google Scholar] [CrossRef]
  33. Skouta, R.; Morán-Santibañez, K.; Valenzuela, C.A.; Vasquez, A.H.; Fenelon, K. Assessing the Antioxidant Properties of Larrea tridentata Extract as a Potential Molecular Therapy against Oxidative Stress. Molecules 2018, 23, 1826. [Google Scholar] [CrossRef] [PubMed]
  34. Morán-Santibañez, K.; Vasquez, A.H.; Varela-Ramirez, A.; Henderson, V.; Sweeney, J.; Odero-Marah, V.; Fenelon, K.; Skouta, R. Larrea tridentata Extract Mitigates Oxidative Stress-Induced Cytotoxicity in Human Neuroblastoma SH-SY5Y Cells. Antioxidants 2019, 8, 427. [Google Scholar] [CrossRef]
  35. Vázquez-Cervantes, G.I.; Villaseñor-Aguayo, K.; Hernández-Damián, J.; Aparicio-Trejo, O.; Medina-Campos, O.N.; López-Marure, R.; Pedraza-Chaverri, J. Antitumor Effects of Nordihydroguaiaretic Acid (NDGA) in Bladder T24 Cancer Cells are Related to Increase in ROS Production and Mitochondrial Leak Respiration. Nat. Prod. Commun. 2018, 13, 1523–1526. [Google Scholar] [CrossRef]
  36. Probst, L.; Dächert, J.; Schenk, B.; Fulda, S. Lipoxygenase inhibitors protect acute lymphoblastic leukemia cells from ferroptotic cell death. Biochem. Pharmacol. 2017, 140, 41–52. [Google Scholar] [CrossRef] [PubMed]
  37. Zhang, L.J.; Wu, J.; Xing, D.M.; Liu, Y.; Jia, F.H.; Li, D.T. Nordihydroguaiaretic Acid (NDGA) Promotes Functional Recovery after Transient Focal Cerebral Ischemia in Rats. Lat. Am. J. Pharm. 2014, 33, 994–1000. [Google Scholar]
  38. Kim, H.G.; Oh, M.S. Herbal medicines for the prevention and treatment of Alzheimer’s disease. Curr. Pharm. Des. 2012, 18, 57–75. [Google Scholar] [PubMed]
  39. Siddique, Y.H.; Ali, F. Protective effect of nordihydroguaiaretic acid (NDGA) on the transgenic Drosophila model of Alzheimer’s disease. Chem.-Biol. Interact. 2017, 269, 59–66. [Google Scholar] [CrossRef] [PubMed]
  40. Tovar-Carrillo, K.L.; Saucedo-Acuña, R.A.; Ríos-Arana, J.; Tamayo, G.; Guzmán-Gastellum, D.A.; Díaz-Torres, B.A.; Nava-Martínez, S.D.; Espinosa-Cristóbal, L.F.; Cuevas-González, J.C. Synthesis, Characterization, and In Vitro and In Vivo Evaluations of Cellulose Hydrogels Enriched with Larrea tridentata for Regenerative Applications. BioMed. Res. Int. 2020, 2020, 1425402. [Google Scholar] [CrossRef]
  41. Del Vecchyo-Tenorio, G.; Rodríguez-Cruz, M.; Andrade-Cetto, A.; Cárdenas-Vázquez, R. Creosote Bush (Larrea tridentata) Improves Insulin Sensitivity and Reduces Plasma and Hepatic Lipids in Hamsters Fed a High Fat and Cholesterol Diet. Front. Pharmacol. 2016, 7, 194. [Google Scholar] [CrossRef]
  42. Chan, J.K.W.; Bittner, S.; Bittner, A.; Atwal, S.; Shen, W.J.; Inayathullah, M.; Rajada, J.; Nicolls, M.R.; Kraemer, F.B.; Azhar, S. Nordihydroguaiaretic Acid, a Lignan from Larrea tridentata (Creosote Bush), Protects against American Lifestyle-Induced Obesity Syndrome Diet-Induced Metabolic Dysfunction in Mice. J. Pharmacol. Exp. Ther. 2018, 365, 281–290. [Google Scholar] [CrossRef]
  43. Han, L.; Bittner, S.; Dong, D.; Cortez, Y.; Dulay, H.; Arshad, S.; Shen, W.J.; Kraemer, F.B.; Azhar, S. Creosote bush-derived NDGA attenuates molecular and pathological changes in a novel mouse model of non-alcoholic steatohepatitis (NASH). Mol. Cell Endocrinol. 2019, 498, 110538. [Google Scholar] [CrossRef]
  44. Zuntilde, A.; Tapia, E.; Zazueta, C.; Correa, F.; Zatarain-Barron, Z.L.; Hernandez, P.R.; Zarco-Marquez, G.; Medina-Campos, O.N.; Pedraza-Chaverri, J. Nordihydroguaiaretic acid pretreatment prevents ischemia and reperfusion induced renal injury, oxidant stress and mitochondrial alterations. J. Med. Plants Res. 2012, 6, 2938–2947. [Google Scholar]
  45. Zúñiga-Toalá, A.; Zatarain-Barrón, Z.L.; Hernández-Pando, R.; Negrette-Guzmán, M.; Huerta-Yepez, S.; Torres, I.; Pinzón, E.; Tapia, E.; Pedraza-Chaverri, J. Nordihydroguaiaretic acid induces Nrf2 nuclear translocation in vivo and attenuates renal damage and apoptosis in the ischemia and reperfusion model. Phytomedicine 2013, 20, 775–779. [Google Scholar] [CrossRef] [PubMed]
  46. Rojo, A.I.; Medina-Campos, O.N.; Rada, P.; Zúñiga-Toalá, A.; López-Gazcón, A.; Espada, S.; Pedraza-Chaverri, J.; Cuadrado, A. Signaling pathways activated by the phytochemical nordihydroguaiaretic acid contribute to a Keap1-independent regulation of Nrf2 stability: Role of glycogen synthase kinase-3. Free Radic. Biol. Med. 2012, 52, 473–487. [Google Scholar] [CrossRef] [PubMed]
  47. Xue, H.; Zhang, X.Y.; Liu, J.M.; Song, Y.; Liu, T.T.; Chen, D. NDGA reduces secondary damage after spinal cord injury in rats via anti-inflammatory effects. Brain Res. 2013, 1516, 83–92. [Google Scholar] [CrossRef] [PubMed]
  48. García-López, J.C.; Lee-Rangel, H.A.; López, S.; Vicente, J.; Pardio-Sedas, V.; Estrada-Coates, A.T.; Pinos-Rodríguez, J.M. Effects of Larrea tridentata on growth, organ weights and hepatic enzymes of broilers. Agrociencia 2018, 52, 1–8. [Google Scholar]
  49. Hernández-Baez, I.; García-López, J.C.; Espinosa-Reyes, G.; Lee-Rangel, H.A.; Faz-Colunga, D.A.; Pinos-Rodríguez, J.M. Biomasa de gobernadora (Larrea tridentata) como forraje para borregos. Rev. Chapingo Serie Zonas Áridas 2019, 18, 1–9. [Google Scholar] [CrossRef]
  50. Roškar, I.; Štrukelj, B.; Lunder, M. Screening of Phenolic Compounds Reveals Inhibitory Activity of Nordihydroguaiaretic Acid against Three Enzymes Involved in the Regulation of Blood Glucose Level. Plant Foods Hum. Nutr. 2016, 71, 88–89. [Google Scholar] [CrossRef]
  51. Favela-Hernández, J.M.; Clemente-Soto, A.F.; Balderas-Rentería, I.; Garza-González, E.; del Camacho-Corona, M. Potential mechanism of action of 3’-demethoxy-6-O-demethyl-isoguaiacin on methicillin resistant Staphylococcus aureus. Molecules 2015, 20, 12450–12458. [Google Scholar] [CrossRef] [Green Version]
  52. Mendez, M.; Rodríguez, R.; Ruiz, J.; Morales-Adame, D.; Castillo, F.; Hernández-Castillo, F.D.; Aguilar, C.N. Antibacterial activity of plant extracts obtained with alternative organics solvents against food-borne pathogen bacteria. Ind. Crops Prod. 2012, 37, 445–450. [Google Scholar] [CrossRef]
  53. Snowden, R.; Harrington, H.; Morrill, K.; Jeane, L.; Garrity, J.; Orian, M.; Lopez, E.; Rezaie, S.; Hassberger, K.; Familoni, D.; et al. A comparison of the anti-Staphylococcus aureus activity of extracts from commonly used medicinal plants. J. Altern. Complement. Med. 2014, 20, 375–382. [Google Scholar] [CrossRef]
  54. Martins, S.; Amorim, E.L.C.; Sobrinho, T.J.S.P.; Saraiva, A.M.; Pisciottano, M.N.C.; Aguilar, C.N.; Teixeira, J.A.; Mussatto, S.I. Antibacterial activity of crude methanolic extract and fractions obtained from Larrea tridentata leaves. Ind. Crops Prod. 2013, 41, 306–311. [Google Scholar] [CrossRef]
  55. Cunningham-Oakes, E.; Soren, O.; Moussa, C.; Rathor, G.; Liu, Y.; Coates, A.; Hu, Y. Nordihydroguaiaretic acid enhances the activities of aminoglycosides against methicillin-sensitive and resistant Staphylococcus aureus in vitro and in vivo. Front. Microbiol. 2015, 6, 1195. [Google Scholar] [CrossRef] [PubMed]
  56. Reyes-Melo, K.; García, A.; Romo-Mancillas, A.; Garza-González, E.; Rivas-Galindo, V.M.; Miranda, L.D.; Vargas-Villarreal, J.; Favela-Hernández, J.M.J.; del Camacho-Corona, M.R. meso-Dihydroguaiaretic acid derivatives with antibacterial and antimycobacterial activity. Bioorg. Med. Chem. 2017, 25, 5247–5259. [Google Scholar] [CrossRef] [PubMed]
  57. Gerstel, J.; Turner, T.; Ruiz, G.; Wise, J.; Stein, A.; Jones, G.; Morin, T.; Pinazza, T.; Sukhorukov, E.; Clark, D.; et al. Identification of botanicals with potential therapeutic use against methicillin-resistant Staphylococcus aureus (MRSA) infections. Phytother. Res. 2018, 32, 2577–2585. [Google Scholar] [CrossRef] [PubMed]
  58. Itzá-Ortiz, M.; Chávez, J.; Urquizo, E.; Suescún, J. Phytobiotic activity of Larrea tridentata, Origanum vulgare and Plectranthus amboinicus in gram positive and gram negative bacterias. Interciencia 2019, 44, 298–302. [Google Scholar]
  59. Núñez-Mojica, G.; Hernández-Carrillo, M.L.; Avalos-Alanís, F.G.; Garza-González, E.; Rivas-Galindo, V.M.; Silva-Mares, D.A.; Camacho-Corona, M.R. Amino ether analogues of 4,4′-dihydroxy-3-methoxy-6,7′-cyclolignan and their activity against drug-resistant bacteria. Phytochem. Lett. 2022, 50, 57–60. [Google Scholar] [CrossRef]
  60. Turner, T.; Ruiz, G.; Gerstel, J.; Langland, J. Characterization of the antibacterial activity from ethanolic extracts of the botanical, Larrea tridentata. BMC Complement. Med. Ther. 2021, 21, 177. [Google Scholar] [CrossRef]
  61. Morales-Ubaldo, A.L.; Gonzalez-Cortazar, M.; Zaragoza-Bastida, A.; Meza-Nieto, M.A.; Valladares-Carranza, B.; Alsayegh, A.A.; El-Saber, B.G.; Rivero-Perez, N. nor 3’-Demethoxyisoguaiacin from Larrea tridentata Is a Potential Alternative against Multidrug-Resistant Bacteria Associated with Bovine Mastitis. Molecules 2022, 27, 3620. [Google Scholar] [CrossRef]
  62. World Health Organization (WHO). Tuberculosis. Available online: https://www.who.int/news-room/fact-sheets/detail/tuberculosis (accessed on 17 September 2021).
  63. Clemente-Soto, A.F.; Balderas-Rentería, I.; Rivera, G.; Segura-Cabrera, A.; del Garza-González, E.R.; Camacho-Corona, M. Potential mechanism of action of meso-dihydroguaiaretic acid on Mycobacterium tuberculosis H37Rv. Molecules 2014, 19, 20170–20182. [Google Scholar] [CrossRef]
  64. Guzmán-Beltrán, S.; Rubio-Badillo, M.Á.; Juárez, E.; Hernández-Sánchez, F.; Torres, M. Nordihydroguaiaretic acid (NDGA) and α-mangostin inhibit the growth of Mycobacterium tuberculosis by inducing autophagy. Int. Immunopharmacol. 2016, 31, 149–157. [Google Scholar] [CrossRef]
  65. Pollara, J.J.; Laster, S.M.; Petty, I.T.D. Inhibition of poxvirus growth by Terameprocol, a methylated derivative of nordihydroguaiaretic acid. Antivir. Res. 2010, 88, 287–295. [Google Scholar] [CrossRef]
  66. Camacho-Corona, M.R.; García., A.; Mata-Cárdenas, B.D.; Garza-González, E.; Ibarra-Alvarado, C.; Rojas-Molina, A.; Rojas-Molina, I.; Bah, M.; Sánchez, M.A.Z.; Gutierrez, S.P. Screening for antibacterial and antiprotozoal activities of crude extracts derived from Mexican medicinal plants. Afr. J. Tradit. Complement. Altern. Med. 2015, 12, 104–112. [Google Scholar] [CrossRef]
  67. Bashyal, B.; Li, L.; Bains, T.; Debnath, A.; LaBarbera, D.V. Larrea tridentata: A novel source for anti-parasitic agents active against Entamoeba histolytica, Giardia lamblia and Naegleria fowleri. PLoS Negl. Trop. Dis. 2017, 11, 1–19. [Google Scholar] [CrossRef] [PubMed]
  68. García, J.E.; Gómez, L.; Mendoza-de-Gives, P.; Rivera-Corona, J.L.; Millán-Orozco, J.; Ascacio, J.A.; Medina, M.A.; Mellado, M. Anthelmintic efficacy of hydro-methanolic extracts of Larrea tridentata against larvae of Haemonchus contortus. Trop Anim. Health Prod. 2018, 50, 1099–1105. [Google Scholar] [CrossRef] [PubMed]
  69. Castillo, F.; Hernández, D.; Gallegos, G.; Mendez, M.; Rodríguez, R.; Reyes, A.; Aguilar, C.N. In vitro antifungal activity of plant extracts obtained with alternative organic solvents against Rhizoctonia solani Kühn. Ind. Crops Prod. 2010, 32, 324–328. [Google Scholar] [CrossRef]
  70. Osorio, E.; Flores, M.; Hernández, D.; Ventura, J.; Rodríguez, R.; Aguilar, C.N. Biological efficiency of polyphenolic extracts from pecan nuts shell (Carya Illinoensis), pomegranate husk (Punica granatum) and creosote bush leaves (Larrea tridentata Cov.) against plant pathogenic fungi. Ind. Crops Prod. 2010, 31, 153–157. [Google Scholar] [CrossRef]
  71. Chávez-Solís, A.L.; Pedroza-Sandoval, A.; Nava-Díaz, C.; Cano-Rios, P.; Castro-Franco, R. Control de la cenicilla del melón (Podosphaera xanthii) mediante el uso de extracto de Larrea tridentata (DC) Coville (I.). RChSZA 2014, 13, 103–113. [Google Scholar] [CrossRef]
  72. Galván, J.V.; Díaz, C.A.G.; Fernández, R.G. Efecto de los extractos acuosos de hojas de plantas de gobernadora (Larreas tridentata), hojas en (Flourensia cernua) y encino (Quercus pungens), sobre el crecimiento micelial in vitro de hongos fitopatógenos. Act. Univ. 2014, 24, 13–19. [Google Scholar]
  73. Munguía, A.R.; Zárate, M.A.; Inungaray, M.L.C. Efecto del uso combinado de extracto de Larrea tridentata y sorbato de potasio sobre el crecimiento de Aspergillus flavus. ReIbCi 2014, 1, 263–267. [Google Scholar]
  74. Castillo-Reyes, F.; Hernández-Castillo, F.D.; Clemente-Constantino, J.A.; Gallegos-Morales, G.; Rodríguez-Herrera, R.; Aguilar, C. In vitro antifungal activity of polyphenols-rich plant extracts against Phytophthora cinnamomi Rands. Afr. J. Agric. Res. 2015, 10, 4554–4560. [Google Scholar] [CrossRef]
  75. Peñuelas-Rubio, O.; Arellano-Gil, M.; Vargas-Arispuro, I.d.C.; Lares-Villa, F.; Cantú-Soto, E.; Hernández-Rodríguez, S.; Gutiérrez-Coronado, M.A.; Mungarro-Ibarra, C. Bioactividad in vitro de extractos de gobernadora (Larrea tridentata) sobre la inhibición de hongos poscosecha: Alternaria tenuissima, Aspergillus niger, Penicillium polonicum y Rhizopus oryzae. Polibotánica 2015, 40, 183–198. [Google Scholar] [CrossRef]
  76. Peñuelas-Rubio, O.; Arellano-Gil, M.; Verdugo-Fuentes, A.A.; Chaparro-Encinas, L.A.; Hernández-Rodríguez, S.E.; Martínez-Carrillo, J.L.; Vargas-Arispuro, I.d.C. Extractos de Larrea tridentata como una estrategia ecológica contra Fusarium oxysporum radicis-lycopersici en plantas de tomate bajo condiciones de invernadero. Rev. Mex. Fitopatol. 2017, 35, 360–376. [Google Scholar] [CrossRef]
  77. Morales-Ubaldo, A.L.; Rivero-Perez, N.; Avila-Ramos, F.; Aquino-Torres, E.; Prieto-Méndez, J.; Hetta, H.F.; El-Saber, B.G.; Zaragoza-Bastida, A. Bactericidal Activity of Larrea tridentata Hydroalcoholic Extract against Phytopathogenic Bacteria. Agronomy 2021, 11, 957. [Google Scholar] [CrossRef]
  78. Méndez-Andrade, R.; Vallejo-Perez, M.R.; Loera-Alvarado, E.; de los Santos-Villarreal, G.; García-Cerda, L.A.; Vera-Reyes, I. Efficacy of biosynthesized silver nanoparticles from Larrea tridentata against Clavibacter michiganensis. J. Phytopathol. 2022, 170, 91–99. [Google Scholar] [CrossRef]
  79. Marín-Domínguez, M.; Pérez-Leal, R.; Núñez-Barrios, A.; Basurto-Sotelo, M.; Soto-Parra, J.M. Exposition of Pecan Black Aphid (Melanocallis caryaefoliae) to creseote bush (Larrea tridentata) extracts. J. Agric. Sci. 2014, 5, 1369. [Google Scholar] [CrossRef]
  80. Maldonado-Simán, E.; Chavarría-Sánchez, P.A.; Martinez-Hernandez, P.A.; Amendola-Massiotti, R.D.; Gonzalez-Garduno, R.; Hernandez-Valencia, E. Horn fly (Haematobia irritans) incidence on cows sprayed with creosote-bush (Larrea tridentata (DC.) Coville) leaf extract. Agrociencia 2018, 52, 323–331. [Google Scholar]
  81. Galarza-Tristán, F.; Aldama-Aguilera, C.; Hipólito-Cruz, G.; González-Montero, R.; Medellín-Castillo, N.; Bernal-Jacomé, L. Extractos vegetales para el control de larvas de mosquitos en diferentes calidades de agua de la ciudad de SLP. Entomol. Mex. 2018, 5, 148–154. [Google Scholar]
  82. Larrey, D.; Faure, S. Herbal medicine hepatotoxicity: A new step with development of specific biomarkers. J. Hepatol. 2011, 54, 599–601. [Google Scholar] [CrossRef]
  83. Higuera-de la Tijera, M.d.F.; Servín-Caamaño, A.I.; Alexanderson-Rosas, E.G. Toxicidad hepática inducida por fármacos y herbolaria. Rev. Med. Hosp. Gen. 2012, 75, 230–237. [Google Scholar]
  84. Brown, A.C. Kidney toxicity related to herbs and dietary supplements: Online table of case reports. Part 3 of 5 series. Food Chem. Toxicol. 2017, 107, 502–519. [Google Scholar] [CrossRef]
  85. Kotsiou, A.; Christine, T. Hepatotoxicity of herbal medicinal products. J. Med. Plant Stud. 2017, 5, 80–88. [Google Scholar]
  86. Vilas-Boas, V.; Gijbels, E.; Jonckheer, J.; De Waele, E.; Vinken, M. Cholestatic liver injury induced by food additives, dietary supplements and parenteral nutrition. Environ. Int. 2020, 136, 105422. [Google Scholar] [CrossRef] [PubMed]
Table 1. Taxonomic classification of Larrea tridentata.
Table 1. Taxonomic classification of Larrea tridentata.
Taxonomy
KingdomPlantae
DivisionTracheophyta
ClassMagnoliopsida
OrderZygophyllales
FamilyZygophyllaceae
GenusLarrea
SpeciesTridentata
Table 2. Chemical structure of bioactive molecules isolated from L. tridentata from the International Union of Pure and Applied Chemistry (IUPAC).
Table 2. Chemical structure of bioactive molecules isolated from L. tridentata from the International Union of Pure and Applied Chemistry (IUPAC).
CompoundClass of CompoundIUPAC NameChemical Structure
Ellagic acidorganic heterotetracyclic compound, polyphenol6,7,13,14-tetrahydroxy-2,9-dioxatetracyclo [6.6.2.04,16.011,15]hexadeca-1(15),4,6,8(16),11,13-hexaene-3,10-dioneMolecules 27 05393 i001
Gallic acidtrihydroxybenzoic acid3,4,5-trihydroxybenzoic acidMolecules 27 05393 i002
CatechinsHydroxyflavanoids2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triolMolecules 27 05393 i003
Methyl gallateGallate estermethyl 3,4,5-trihydroxybenzoateMolecules 27 05393 i004
Cinnamic acidMonocarboxylic acid,
a styrene
(E)-3-phenylprop-2-enoic acidMolecules 27 05393 i005
ResorcinolBenzenediolbenzene-1,3-diolMolecules 27 05393 i006
Kaempferol Flavonol (tetrahydroxyflavone)3,5,7-trihydroxy-2-(4-hydroxyphenyl)chromen-4-oneMolecules 27 05393 i007
QuercetinFlavonoid2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxychromen-4-oneMolecules 27 05393 i008
Nordihydroguaiaretic acid (NDGA)Lignan4-[4-(3,4-dihydroxyphenyl)-2,3-dimethylbutyl]benzene-1,2-diolMolecules 27 05393 i009
ThymolMonoterpene5-methyl-2-propan-2-ylphenolMolecules 27 05393 i010
CarvacrolMonoterpene2-methyl-5-propan-2-ylphenolMolecules 27 05393 i011
Table 3. Isolated compounds from Larrea tridentata.
Table 3. Isolated compounds from Larrea tridentata.
Organ-ExtractCompoundClass of Compound
Aerial parts, methanolic extract3-[(O-(4-O-sulfo-b-d-glucopyranosyl)-(1→3)-a-L-arabinopyranosyl) oxy]olean-12-en-28-oic acid b-d-glucopyranosyl ester sodium salt
3-[(O-(4-O-sulfob-d-glucopyranosyl)-(1→3)-O-[a-l-rhamnopyranosyl-(1→2)]-a-Larabinopyranosyl)oxy]-30-noroleana-12,20(29)-dien-28-oic acid b-d-glucopyranosyl ester sodium salt
Triterpene glycosides
Aerial parts, methanolic extractLarrealignans A and BLignans
Leaves, chloroformic extractdihydroguaiaretic acid, 4-epilarreatricin, 3′-demethoxy-6-Odemethylisoguaiacin,Lignans
Leaves, chloroformic extract5,4′-dihydroxy-3,7,8,3′-tetramethoxyflavone
5,4′-dihydroxy-3,7,8-trimethoxyflavone
5,4′-dihydroxy-7-methoxyflavone
5,8,4′-trihydroxy-3,7-dimethoxyflavone
Flavonoids
Aerial parts, dichloromethane extract3,4-dehydrolarreatricin
meso-dihydroguaiaretic acid
3-O-methyldihydroguaiaretic acid
3-O-demethylisoguaiacin
Lignans
Aerial parts, dichloromethane extract3′-oxohexyl ferulateFerulic acid ester
Aerial parts, dichloromethane extractNaringenin
3′-O-methyltaxifolin
apigenin-7-methylether
Kaempferol-3,7-dimethylether
herbacetin-3,7-dimethylether
Flavonoids
Leaves, hexane extract4,4′-dihydroxy-3-methoxy-6,7′-cyclolignan
3,4-dihydroxy-3′,4′-dimethoxy-6,7′-cyclolignan
Cyclolignans
Table 4. Pharmacological activities of L. tridentata its related compounds and mechanism of action.
Table 4. Pharmacological activities of L. tridentata its related compounds and mechanism of action.
ActivitiesBioactive CompoundsMechanism of ActionReference
AntioxidantNDGA, Quercetin, Kaempferol, Justicidin B and Beta peltainMitigation of cutaneous lipid peroxidation and cytotoxicity, inhibition of production of hydrogen peroxide and edema formation, reduction of apoptosis hallmarks[30,31,32,33,34]
Antitumor NDGAInduction of mitochondrial alterations, ferroptosis.[35,36]
NeuroprotectiveNDGAPromotion of neurogenesis and angiogenesis, anti-apoptotic, reduction of the neurotoxic, motor and cognitive impairments of Alzheimer´s disease[37,38,39]
Regenerative Not indicatedInhibition of inflammation or toxicity[40]
Hepatoprotective NDGALower lipid peroxidation, increase in antioxidant capacity in the liver[41,42,43]
Renal effectsNDGADecreasing the activity of renal antioxidant enzymes, affection of mitochondrial activities.[44,45,46]
Anti-inflammatoryNDGAReduction in myeloperoxidase activity, reduced edema response, decrease of inflammatory factors[31,47]
HypoglycemicNDGAInhibition of α-amylase, α-glucosidase and dipeptidyl peptidase 4[50]
Table 5. Pharmacological activities of Larrea tridentata related to infectious diseases.
Table 5. Pharmacological activities of Larrea tridentata related to infectious diseases.
ActivitiesBioactive CompoundMechanism of ActionReference
Antibacterial activitySeveral bioactive
Compounds
Affecting proteins of ABC transport system causing bacteria death, bacterial retardation, bacteriostatic, permeabilizing membrane[12,27,51,52,53,54,55,56,58,59,60,61]
Antimycobacterial activityLignans, flavonoids,
meso-dihydroguaiaretic acid, NDGA
Growth inhibition, bactericidal[27,55,58,59,64]
Antiviral activityTerameprocol (TMP)Inhibition of poxvirus growth[65]
Antiprotozoal activitySeveral compoundsModulation of cysteine protease activity present in the trophozoites[28,66,67]
Anthelmintic activityHydro methanolic
Extracts
Damaging larvae cuticle, coiling up of worms and lethargic movements[68]
Antifungal activityTannins, polyphenolic extractsFungi-static and fungicidal effects[31,69,70,71,72,73,74,75,76]
Insecticidal activityDifferent extractsRepellent effect, causing death of
mosquito larvae
[79,81]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Morales-Ubaldo, A.L.; Rivero-Perez, N.; Valladares-Carranza, B.; Madariaga-Navarrete, A.; Higuera-Piedrahita, R.I.; Delgadillo-Ruiz, L.; Bañuelos-Valenzuela, R.; Zaragoza-Bastida, A. Phytochemical Compounds and Pharmacological Properties of Larrea tridentata. Molecules 2022, 27, 5393. https://doi.org/10.3390/molecules27175393

AMA Style

Morales-Ubaldo AL, Rivero-Perez N, Valladares-Carranza B, Madariaga-Navarrete A, Higuera-Piedrahita RI, Delgadillo-Ruiz L, Bañuelos-Valenzuela R, Zaragoza-Bastida A. Phytochemical Compounds and Pharmacological Properties of Larrea tridentata. Molecules. 2022; 27(17):5393. https://doi.org/10.3390/molecules27175393

Chicago/Turabian Style

Morales-Ubaldo, Ana Lizet, Nallely Rivero-Perez, Benjamín Valladares-Carranza, Alfredo Madariaga-Navarrete, Rosa Isabel Higuera-Piedrahita, Lucía Delgadillo-Ruiz, Rómulo Bañuelos-Valenzuela, and Adrian Zaragoza-Bastida. 2022. "Phytochemical Compounds and Pharmacological Properties of Larrea tridentata" Molecules 27, no. 17: 5393. https://doi.org/10.3390/molecules27175393

Article Metrics

Back to TopTop